Transforming Patient Care with Dermal Drug Delivery Systems
Beyond Blood Cancers - CAR-T’s Expanding Frontier
Translating Nanomedicine Potential into a Scalable Reality with Flow Manufacturing
Optimising Clinical Trial Start-Up
From Reactive to Proactive - The Strategic Imperative for Eliminating Risk in Pharmaceutical Stability Studies
EDITORIAL SECTION
-
STRATEGY
Smarter Pharma
Quality management systems QMS are the backbone of pharmaceutical manufacturing ensuring safe products
-
RESEARCH DEVELOPMENT
Cytiva Laboratory capsule filters
Our singleuse selfcontained filtration solution
-
CLINICAL TRIALS
Why Clinical Trials Need Digital Endpoints
According Citeline the average success rate for bringing a Phase candidate to market has dropped to an alltime low of just
-
MANUFACTURING
Ensuring Quality and Compliance in Biopharma
Ensuring quality and regulatory compliance in the biopharmaceutical industry is critical to safeguarding product safety and efficacy
-
Information Technology
The Cost of Bad Data
Modern pharmaceutical research generates an unprecedented volume of information Data from genomic sequencing
-
Biopharma
Reimagining Global Biomanufacturing Capacity with Continuous and Modular Systems
Biotechnology is fueling the ongoing expansion of the global market for a broad array of goods
-
EXPERT Talk
Where Technology Thinks Small: AI and Nanomedicine in Harmony
Over the next decade the fusion of nanomedicine and AI will redefine the treatment of neurodegenerative diseases from merely managing symptoms to offering precisionmodifying therapy Smart nanocarriers will be engineered to traverse the bloodbrain barrier target specific brain cells and deliver controlled payloads
Advisory Board
.webp)
KNOWLEDGE BANK
-
Articles
Advancing Pharmaceutical Manufacturing with Robotics and Automation
The pharmaceutical sector is experiencing one of the most fundamental changes ever in its history triggered by the booming growth of robotics intelligent automation and AIdriven manufacturing systems Developing new and improved drugs and with increased demands on the globe the old processes based on manual labor and fragmentation are no longer able to produce drugs as quickly precisely and in larg...
-
Techno Trends
Alkermes Secures FDA Breakthrough Therapy Status for Alixorexton in Narcolepsy Type 1
Alkermes plc has announced that the US Food and Drug Administration has granted Breakthrough Therapy designation to alixorexton for the treatment of narcolepsy type NT
-
Projects
FUJIFILM Invests £400M to Expand Biomanufacturing and Process Development Capacity
FUJIFILM Biotechnologies a global contract development and manufacturing organisation CDMO for biologics vaccines and advanced therapies has expanded its site in Teesside UK with a total investment
-
Research Insights
Development of niosomal nanoparticles loaded with cisplatin and vorinostat combination for cancer therapy
Cisplatin CIS remains a cornerstone of chemotherapy but is limited by resistance and systemic toxicity Combining DNAdamaging agents with epigenetic modulators such as vorinostat VOR offers
-
whitepaper
Smoothing the Path to Drug Development with Accurate Clinical Data
Drug development is a long costly and complex process At its core lies a critical question How does a drug affect the bodyand how does the body respond The answers are derived from wellstructured pharmacokinetic PK pharmacodynamic PD
TOP ARTICLES
-
1
Ritonavir: How the Discovery of a New Polymorph Changed Drug Development Forever
Victor M. Diaz Perez
The ritonavir crisis, triggered by the unexpected discovery of a new, less soluble polymorph, reshaped the pharmaceutical industry's approach to solid state characterization. This article explores...
-
2
COVID-19 Vaccines & SARS-CoV-2 Variants: Who is winning the Race?
Kenneth Lundstrom
Although COVID-19 vaccines have proven efficient and safe, the continuous emergence of novel SARS-CoV-2 mutants, properly called variants of concern, has resulted in a race between vaccine efficacy an...
-
3
Quantum Dot: The Future of Personalized Medicine
Chandan Adhikari
Certainly, we are all alike, but we are all unique. And the notion that medication would be used in a way that overlooks those disparities is as absurd as walking to a sneaker store to pick up any old...
-
4
What is Clinical Drug Trials and what are the four phases of clinical trials
James A Uchizono
A clinical study involves exploration using mortal levies( also called actors) that's intended to add to medical knowledge. There are two main types of clinical studies clinical trials( also calle...
-
5
Advancing Pharmaceutical Manufacturing with Robotics and Automation
Kate Williamson
Robotics and smart automation are improving to change the pharmaceutical manufacturing industry to further increase precision, quality, and efficiency. These systems make drug manufacturing straightfo...
press releases Read more...
FUJIFILM Biotechnologies Unveils ShunzymeX™ precision purification technology
FUJIFILM Biotechnologies a world leading contract development and manufacturing organization CDMO for biologics vaccines and advanced therapies today unveils ShunzymeX precision purification technology
T-knife Therapeutics Announces Authorization of Clinical Trial Application for TK-6302, A Multi-Armored, CRISPR based T cell Therapy for Solid Tumors
Tknife Therapeutics Inc a biopharmaceutical company developing nextgeneration T cell therapies to fight cancer today announced the authorization of its Clinical Trial Application CTA to begin the Phase ATLAS trial of TK in Europe
Thermo Fisher Scientific Launches New Color-Based (Chromogenic) Culture Media to Help Detect Candida Infections Faster*, Including Drug-Resistant Candida auris
Thermo Fisher Scientific the world leader in serving science today announced the launch of Thermo Scientific Brilliance Candida Agar and Spectra Candida Agar new colorbased chromogenic culture media
Advancing Influenza Vaccine Development: Sino Biological Launches Antigens for the 2026-2027 Northern Hemisphere Influenza Vaccine Strains
The World Health Organization WHO has announced its recommendations for the Northern Hemisphere influenza vaccine composition The update highlights two key developments the continued spread of A HN subclade
Events Read more...
05 - 06
Mar 2026ImmunoMark Summit 2026
DoubleTree by Hilton London | Tower of London, UK
09 - 11
Mar 20268th International Conference
8105, Suite 112, Rasor Blvd, Plano TX 75024, USA
10 - 12
Mar 2026Bioprocessing Summit Europe 2026
InterContinental Barcelona, Spain
10 - 10
Mar 2026Age of AI Europe 2026
Institute of Engineering and Technology (IET) London,UK
10 - 12
Mar 2026Healthcare & Hospi.Log Asia 2026
Singapore
10 - 12
Mar 20269th Annual Pharma Regulatory Summit 2026
Mumbai, India
16 - 17
Mar 2026Pharma USA 2026
Philadelphia, PA, USA
16 - 18
Mar 2026Pharmaceutics and Novel Drug
Kuala Lumpur, Malaysia
LATEST NEWS Read more...
Antengene and UCB Sign Global Licence Agreement for ATG-201 in Autoimmune Diseases
Antengene Corporation Limited and UCB have entered into a global licence agreement for ATG a CDCD bispecific Tcell engager TCE for autoimmune diseases
EU Advances Critical Medicines Act for Supply Chain Resilience
The EU Parliament has advanced the Critical Medicines Act to enhance pharmaceutical supply chain security and resilience across Europe starting in
Novo Nordisk to Invest Over €400 Million in Athlone Manufacturing Plant Expansion
Novo Nordisk has announced an investment of million approximately DKK billion to expand its manufacturing plant in Monksland Athlone Ireland The site produces tabletbased medicines and the upgrade will increase capacity for current and future GLP treatments
Sanofi’s Rilzabrutinib Granted Orphan Drug Status in Japan for IgG4-Related Disease
Sanofi has received orphan drug designation in Japan for rilzabrutinib for the treatment of IgGrelated disease IgGRD The designation was granted by Japans Ministry of Health Labour and Welfare for medicines intended to treat rare conditions with high unmet medical need
EU Advances Critical Medicines Act for Pharma Supply Chain Resilience
The EU Parliament has advanced the Critical Medicines Act to strengthen Europes pharmaceutical supply chain security and resilience starting in
Neurogene announces FDA Breakthrough Therapy designation for NGN-401 in Rett syndrome
Neurogene Inc has announced that the US Food and Drug Administration FDA has granted Breakthrough Therapy designation to NGN its investigational gene therapy for Rett syndrome
